We demonstrated that LETM2 promotes tumor progression by activating the mTOR pathway, thereby inducing mitochondrial homeostasis and facilitating glycolysis, ultimately leading to accelerated proliferation of GC cells. This evidence concerns the gene MTOR and gastric cancer.